期刊文献+

离子交换色谱法分离纯化胸腺肽α_1的工艺研究 被引量:1

Studies on the Isolation and Purification of Thymosin α_1 by Ion-exchange Chromatography
下载PDF
导出
摘要 通过对胸腺肽α1的分离纯化,提高胸腺肽α1的纯度,确定简单可行的纯化工艺技术。将QAE Sephadex A-25和D208、D301、717等阴离子交换介质进行静态吸附实验,确定最适离子交换介质;通过L(933)正交试验对流速、填料高度及进样浓度进行优化,确定最佳分离条件。以QAE Sephadex A-25作为填料介质吸附胸腺肽α1,在流速60 cm/h,填料高度50 cm,进样浓度8 mg/mL条件下,胸腺肽α1纯化效果理想,经HPLC测定,得到纯度达24.596 6 mg/mL的胸腺肽α1,质量分数达12.03%,比市场上销售的胸腺肽中Tα1含量(质量分数0.6%~1.0%)高出近10倍。 Through purifying thymosin α1and improve the purity of thymosin α1 in order to research a simple and feasible purification technology.The study chooses QAE Sephadex A-25 and D208,D301,717 ect.for static IV adsorption experiment through the anion exchange chromatography in order to determine the optimum ion exchange media;The optimal experiment conditions of the eluent,eluting style,flow rate,height of media are studied and choose L9(33) orthogonal experiment on optimizing the conditions of the velocity,height and the concentration.The study chooses HPLC and SDS-PAGE to identifying the thymosin α1.The experiment showed that the QAE Sephadex A-25 as a filler media adsorbing thymosin α1 makes the best effect,the velocity is 60 cm/h,packing height is 50 cm,the concentration is 8 mg/mL,then the purification results is satisfactory.Determined by the HPLC,the purity of thymosin α1is 24.596 6 mg/mL,the mass percent is 12.03 %.The method is accurate and feasible.The purity of thymosin α1is 10 times higher than the commercial thymosin α1 products(the mass percent is 0.6 % to 1.0 %).
出处 《食品研究与开发》 CAS 北大核心 2013年第12期20-25,共6页 Food Research and Development
基金 黑龙江省科技攻关项目(NOGB 06B0403-3)
关键词 胸腺肽Α1 离子交换色谱 分离纯化 Thymosin α1 ion-exchange chromatography isolation and purification
  • 相关文献

参考文献5

二级参考文献24

  • 1李聚海,岳田利,袁亚宏.辅酶Q_(10)超声波破碎法提取工艺条件研究[J].西北农林科技大学学报(自然科学版),2007,35(5):207-211. 被引量:18
  • 2秦伟涛,陈劲春,李冬冬.一种简便快速工艺制备重组人胸腺肽α_1[J].北京化工大学学报(自然科学版),2007,34(3):296-299. 被引量:3
  • 3Miller JFAP. Immunologic function of the thymus[J]. Lancet, 1961, 2:748 - 749.
  • 4Goldstein A. L. Thymosin alphal: isolation and sequence analysis of an immunologically active thymic polypeptide[J]. Proc Natl Acad Sci USA,1977, 74:725 - 729.
  • 5Goldstein A. L. , Guha A., Zatz M. M., et al. Purification and biological ac -tivity of thymosin, a hormone of the thymus gland[J] Proc Natl Acad Sci USA, 1972, 69:1 800 - 1 803.
  • 6Serrate S, Schulof R, Leondaridis L, et al. 1987 Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones[J]. J Immunol, 1987,139:2338 -2343.
  • 7Kenneth E, Sherman, Charles C, et al. Low thymosin alphal concentrations in patients chronically infected with the hepatitis B virus[J]. Viral Im -munology, 1991, 4(3): 195 - 199.
  • 8Moshier J. A., Mutchnick M. G., Dosescu J., et al. Inhibition of HBV -EPG2 anchorage- independent growgh is enhanced by the combination of thymosin α1 and interferon α[J]. Hepatology, 1994, 20:284-291.
  • 9Hadden JW, Saha A, Sisa M, et al.1995 Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T lymphocyte response of hydrocortisone- treated aged mice[J]. Int J Immunophamacol, 1995, 17:821 - 828.
  • 10Jun H. Serum levels of soluble interleukin-2 receptors and effects of interferon- α for patients with chronic hepatitis C virus[J]. Dig Dis Sci,1995, 40(8): 1 837 - 1 845.

共引文献53

同被引文献19

  • 1Go|dstein AL, Slater FD, White A. Preparation, assay, and par- tial purification of a thymic lymphocytopoietic factor (thymosin) [J]. Proc Natl Acad Sci USA, 1966, 56 (3): 1010-1017.
  • 2Elizondo-Riojas MA, Chamow SM, Tuthill CW, et aL NMR structure of human thymosin alpha-1 [J]. Biochem Biophys Res Commun, 2011, 416 (3-4): 356-361.
  • 3Goldstcin AL, Low TL, McAdoo M, et al. Thymosin alpha 1: isolation and sequence analysis of an immunologically active thymic peptide [J]. Proc Natl Acad Sci USA, 1977, 74 (2):725-729.
  • 4Sandra K, Moshir M, D'hondt F, et al. Highly efficient peptide separations in proteomics. Part 2: bi- and multidimensional liq- uid-based separation techniques [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2009, 877 (11-12): 1019-1039.
  • 5Di Palma S, Hennrich ML, Heck AJ, et ol. Recent advances in peptide separation by multidimensional liquid chromatography for proteome analysis [J]. J Proteomics, 2012, 75 (13): 3791- 3813.
  • 6徐晓,吉春,熊国裕.一种合成胸腺肽α1的分离纯化方法[P]:中国,CN102477094A.
  • 7F61ix G, Joly P, Droux S, et ol. Purification studies of thymosin c-I in LC [J]. ChromatogTaphia, 2009, 70 (3-4): 381-387.
  • 8Li J, Liu CH, Wang FS. Thymosin alpha 1: biological activities, applications and genetic engineering production [J]. Peptides, 2010, 31(11): 2151-2158.
  • 9Li WN, Song LQ, Wu SZ, et cd. Expression, purification and eharaeterization of a novel soluble human thymosin alphal con- eatemer exhibited a stronger stimulation on miee lymphocytes proliferation and higher anti-tumor activity [J]. Int J Biol Sei, 2011, 7 (5): 618-628.
  • 10Xue XC, Yan Z, Li WN, et al. Construction, expression, and characterization of thymosin alpha 1 tandem repeats in Es- cherichia coli [J]. BioMed Res Int, 2013, 2013 (1): 1-6.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部